DK1144459T3 - Tværbundne hyaluronsyrer og medicinske anvendelser deraf - Google Patents

Tværbundne hyaluronsyrer og medicinske anvendelser deraf

Info

Publication number
DK1144459T3
DK1144459T3 DK99968778T DK99968778T DK1144459T3 DK 1144459 T3 DK1144459 T3 DK 1144459T3 DK 99968778 T DK99968778 T DK 99968778T DK 99968778 T DK99968778 T DK 99968778T DK 1144459 T3 DK1144459 T3 DK 1144459T3
Authority
DK
Denmark
Prior art keywords
hyaluronic acids
medical applications
crosslinked hyaluronic
cross
linked hyaluronic
Prior art date
Application number
DK99968778T
Other languages
English (en)
Other versions
DK1144459T4 (da
Inventor
Rolando Barbucci
Roberto Rapuoli
Original Assignee
Aquisitio S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11381033&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1144459(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aquisitio S P A filed Critical Aquisitio S P A
Publication of DK1144459T3 publication Critical patent/DK1144459T3/da
Application granted granted Critical
Publication of DK1144459T4 publication Critical patent/DK1144459T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK99968778.3T 1998-11-11 1999-11-08 Tværbundne hyaluronsyrer og medicinske anvendelser deraf DK1144459T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI002440A IT1303735B1 (it) 1998-11-11 1998-11-11 Acidi ialuronici reticolati e loro usi medici.
PCT/EP1999/008481 WO2000027887A2 (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids and medical uses thereof

Publications (2)

Publication Number Publication Date
DK1144459T3 true DK1144459T3 (da) 2003-02-03
DK1144459T4 DK1144459T4 (da) 2011-06-06

Family

ID=11381033

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99968778.3T DK1144459T4 (da) 1998-11-11 1999-11-08 Tværbundne hyaluronsyrer og medicinske anvendelser deraf

Country Status (24)

Country Link
US (1) US6831172B1 (da)
EP (1) EP1144459B2 (da)
JP (1) JP2002529550A (da)
KR (1) KR100674177B1 (da)
CN (1) CN1131241C (da)
AT (1) ATE225371T1 (da)
AU (1) AU757102B2 (da)
BR (1) BR9915235A (da)
CA (1) CA2350667A1 (da)
CZ (1) CZ296842B6 (da)
DE (1) DE69903351T3 (da)
DK (1) DK1144459T4 (da)
ES (1) ES2184521T5 (da)
HK (1) HK1041011B (da)
HU (1) HU229668B1 (da)
IL (1) IL143063A0 (da)
IT (1) IT1303735B1 (da)
NO (1) NO20012315L (da)
NZ (1) NZ511306A (da)
PT (1) PT1144459E (da)
RU (1) RU2230752C2 (da)
TR (1) TR200101324T2 (da)
WO (1) WO2000027887A2 (da)
ZA (1) ZA200103799B (da)

Families Citing this family (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD980037A1 (it) * 1998-02-25 1999-08-25 Fidia Advanced Biopolymers Srl Acido ialuronico solfatato e i suoi derivati legati covalentemente a polimeri sintetici pe la preparazione di biomateriali e per il rivesti
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
US7068729B2 (en) 2001-12-21 2006-06-27 Digital Fountain, Inc. Multi-stage code generator and decoder for communication systems
US6307487B1 (en) 1998-09-23 2001-10-23 Digital Fountain, Inc. Information additive code generator and decoder for communication systems
IT1303738B1 (it) * 1998-11-11 2001-02-23 Aquisitio S P A Processo di reticolazione di polisaccaridi carbossilati.
DK1140198T3 (da) 1999-01-13 2008-03-10 Alchemia Oncology Pty Ltd Anvendelse af hyaluronan til fremstilling af et lægemiddel til forögelse af cytotoksiske lægemidlers virkningsgrad
KR100338179B1 (ko) * 2000-05-08 2002-05-24 김범철 안질환 치료용 약물 전달을 위한 그래프트 중합체 및 그제조방법
AUPQ879500A0 (en) * 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
US9066919B2 (en) * 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
KR100375299B1 (ko) * 2000-10-10 2003-03-10 주식회사 엘지생명과학 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
ATE409500T1 (de) * 2001-01-16 2008-10-15 Univ Michigan Biokatalytische und biomimetische erzeugung von stickoxid in situ an substrat/blut-grenzflächen
US7128904B2 (en) 2001-01-16 2006-10-31 The Regents Of The University Of Michigan Material containing metal ion ligand complex producing nitric oxide in contact with blood
US7335383B2 (en) 2001-01-16 2008-02-26 The Regents Of The University Of Michigan Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in blood
CA2458856C (en) * 2001-08-27 2011-02-15 Meditech Research Limited Improved therapeutic protocols
US9240810B2 (en) 2002-06-11 2016-01-19 Digital Fountain, Inc. Systems and processes for decoding chain reaction codes through inactivation
KR20040009891A (ko) * 2002-07-26 2004-01-31 주식회사 엘지생명과학 히알루론산의 유도체 겔 및 그 제조방법
JP4546246B2 (ja) 2002-10-05 2010-09-15 デジタル ファウンテン， インコーポレイテッド 連鎖的暗号化反応の系統的記号化および復号化
EP1560543A2 (en) * 2002-10-25 2005-08-10 Essentia Biosystems, Inc. Implantable medical devices using zinc
FR2850282B1 (fr) 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
WO2004081055A1 (ja) * 2003-02-21 2004-09-23 Terumo Kabushiki Kaisha 架橋性多糖誘導体、その製造方法、架橋性多糖組成物および医療用処置材
JP2004262777A (ja) * 2003-02-27 2004-09-24 Shiseido Co Ltd アセチル化ヒアルロン酸含有眼用医薬組成物
AU2003228014B2 (en) * 2003-04-04 2009-11-05 Nobil Bio Ricerche S.R.L. Vascular stent
KR101170629B1 (ko) 2003-10-06 2012-08-02 디지털 파운튼, 인크. 단일 송신기 또는 다중 송신기를 갖는 통신 시스템의 에러 정정 다중-스테이지 코드 생성기 및 디코더
JP4511470B2 (ja) * 2003-10-29 2010-07-28 帝人株式会社 ヒアルロン酸化合物、そのハイドロゲルおよび関節軟骨損傷治療用材料
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
EP1743431A4 (en) 2004-05-07 2007-05-02 Digital Fountain Inc SYSTEM FOR DOWNLOADING AND RECORDING AND CONTINUOUS READING OF FILES
ITMI20041373A1 (it) 2004-07-09 2004-10-09 Lima Lto S P A N-metil-ammidi di carbossimetilcellulosa acido alginico o carbossimetalamido
TW200612991A (en) * 2004-09-07 2006-05-01 Chugai Pharmaceutical Co Ltd Process for producing water-soluble hyaluronic acid modification
CN101056891B (zh) * 2004-11-15 2010-05-26 株式会社资生堂 交联透明质酸凝胶的制备方法
CN101107270B (zh) * 2004-11-24 2011-11-23 诺维信生物制药丹麦公司 用二乙烯基砜交联透明质酸的方法
WO2006069578A1 (en) * 2004-12-30 2006-07-06 Novozymes Biopolymer A/S Hyaluronic acid linked with a polymer of an alpha hydroxy acid
ITPD20050056A1 (it) * 2005-03-02 2006-09-03 Fidia Farmaceutici Derivati ammidici del'acido ialuronico in osteoartrosi
TW200643033A (en) * 2005-03-08 2006-12-16 Chugai Pharmaceutical Co Ltd Conjugate of water-soluble modified hyaluronic acid and glp-1 analogue
US7676735B2 (en) 2005-06-10 2010-03-09 Digital Fountain Inc. Forward error-correcting (FEC) coding and streaming
JP5465431B2 (ja) 2005-07-27 2014-04-09 アルケミア オンコロジー ピーティーワイ リミテッド ヒアルロナンを用いる治療プロトコル
WO2007028196A1 (en) 2005-09-07 2007-03-15 Alchemia Oncology Pty Limited Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
US7879818B2 (en) * 2005-12-23 2011-02-01 Janos Borbely Hyaluronic acid-based cross-linked nanoparticles
KR100737954B1 (ko) * 2006-01-03 2007-07-13 고려대학교 산학협력단 조직재생을 위한 히알루론산-기초된 주사형 하이드로겔
US9136983B2 (en) 2006-02-13 2015-09-15 Digital Fountain, Inc. Streaming and buffering using variable FEC overhead and protection periods
US9270414B2 (en) 2006-02-21 2016-02-23 Digital Fountain, Inc. Multiple-field based code generator and decoder for communications systems
US20100273734A1 (en) * 2006-02-28 2010-10-28 Novozymes Biopolymer A/S Derivatives of Hyaluronic Acids
US7674781B2 (en) * 2006-04-28 2010-03-09 Heather Sheardown Hyaluronic acid-retaining polymers
US7971129B2 (en) 2006-05-10 2011-06-28 Digital Fountain, Inc. Code generator and decoder for communications systems operating using hybrid codes to allow for multiple efficient users of the communications systems
US9209934B2 (en) 2006-06-09 2015-12-08 Qualcomm Incorporated Enhanced block-request streaming using cooperative parallel HTTP and forward error correction
US9380096B2 (en) 2006-06-09 2016-06-28 Qualcomm Incorporated Enhanced block-request streaming system for handling low-latency streaming
US9178535B2 (en) 2006-06-09 2015-11-03 Digital Fountain, Inc. Dynamic stream interleaving and sub-stream based delivery
US9419749B2 (en) 2009-08-19 2016-08-16 Qualcomm Incorporated Methods and apparatus employing FEC codes with permanent inactivation of symbols for encoding and decoding processes
US9432433B2 (en) 2006-06-09 2016-08-30 Qualcomm Incorporated Enhanced block-request streaming system using signaling or block creation
US9386064B2 (en) 2006-06-09 2016-07-05 Qualcomm Incorporated Enhanced block-request streaming using URL templates and construction rules
CN101501075B (zh) * 2006-08-04 2013-07-10 诺维信生物制药丹麦公司 支化透明质酸和制造方法
US20080070993A1 (en) * 2006-09-07 2008-03-20 Janos Borbely Additives for cosmetic products and the like
FR2909285A1 (fr) * 2006-12-01 2008-06-06 Anteis Sa "utilisation d'un gel anti-adhesif et anti fibrotique"
FR2909560B1 (fr) * 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
JP2008255061A (ja) * 2007-04-06 2008-10-23 Shiseido Co Ltd 可溶性架橋ヒアルロン酸含有眼用組成物
WO2009012367A1 (en) * 2007-07-18 2009-01-22 Aesthetic Science Composition and method of use for soft tissue augmentation/drug delivery
EP2178908B1 (en) * 2007-08-15 2013-07-10 Metamorefix Peptides and pharmaceutical compositions for treating connective tissue
AU2008298602A1 (en) 2007-09-12 2009-03-19 Digital Fountain, Inc. Generating and communicating source identification information to enable reliable communications
CA2719666C (en) 2008-04-04 2016-08-16 Glenn Prestwich Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
US8932622B2 (en) * 2008-06-03 2015-01-13 Actamax Surgical Materials, Llc Tissue coating for preventing undesired tissue-to-tissue adhesions
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
WO2010016611A1 (ja) * 2008-08-05 2010-02-11 帝人株式会社 ハイドロゲル
US20100104654A1 (en) 2008-10-27 2010-04-29 Allergan, Inc. Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
FR2938187B1 (fr) * 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
US9281847B2 (en) 2009-02-27 2016-03-08 Qualcomm Incorporated Mobile reception of digital video broadcasting—terrestrial services
US9288010B2 (en) 2009-08-19 2016-03-15 Qualcomm Incorporated Universal file delivery methods for providing unequal error protection and bundled file delivery services
IT1395392B1 (it) * 2009-08-27 2012-09-14 Fidia Farmaceutici Geli viscoelastici come nuovi filler
US9917874B2 (en) 2009-09-22 2018-03-13 Qualcomm Incorporated Enhanced block-request streaming using block partitioning or request controls for improved client-side handling
JP5604072B2 (ja) * 2009-09-28 2014-10-08 テルモ株式会社 活性エステル化多糖およびその製造方法
FR2954945B1 (fr) * 2010-01-04 2012-01-06 Oreal Composition cosmetique ou dermatologique, procede de traitement cosmetique et derive d'acide hyaluronique
US20110280311A1 (en) 2010-05-13 2011-11-17 Qualcomm Incorporated One-stream coding for asymmetric stereo video
CA2805008C (en) * 2010-07-12 2015-05-12 Shin Poong Pharmaceutical Co., Ltd. Filler composition for tissue augmentation comprising a hydrogel of hyaluronic acid cross-linked with alkylene diamine
US9596447B2 (en) 2010-07-21 2017-03-14 Qualcomm Incorporated Providing frame packing type information for video coding
US8806050B2 (en) 2010-08-10 2014-08-12 Qualcomm Incorporated Manifest file updates for network streaming of coded multimedia data
US9270299B2 (en) 2011-02-11 2016-02-23 Qualcomm Incorporated Encoding and decoding using elastic codes with flexible source block mapping
US8958375B2 (en) 2011-02-11 2015-02-17 Qualcomm Incorporated Framing for an improved radio link protocol including FEC
WO2012129461A1 (en) 2011-03-23 2012-09-27 University Of Utah Research Foundation Methods for treating or preventing urological inflammation
RU2477155C2 (ru) * 2011-04-27 2013-03-10 Закрытое акционерное общество "Патент-Фарм" Способ лечения андрогенетической алопеции
US9253233B2 (en) 2011-08-31 2016-02-02 Qualcomm Incorporated Switch signaling methods providing improved switching between representations for adaptive HTTP streaming
US9843844B2 (en) 2011-10-05 2017-12-12 Qualcomm Incorporated Network streaming of media data
CZ303879B6 (cs) * 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
US9294226B2 (en) 2012-03-26 2016-03-22 Qualcomm Incorporated Universal object delivery and template-based file delivery
FR2997014B1 (fr) 2012-10-24 2015-03-20 Teoxane Composition sterile dermo-injectable
FR3005056B1 (fr) * 2013-04-24 2016-04-01 Ayawane Hydrogel a base de polysaccharides natifs et/ou fonctionnalises, phosphates co-reticules
HK1224315A1 (zh) * 2013-06-28 2017-08-18 Galderma S.A. 用於制备交联的透明质酸产物的方法
US9421198B2 (en) 2013-07-30 2016-08-23 Teoxane Composition comprising hyaluronic acid and mepivacaine
ITUD20130119A1 (it) * 2013-09-12 2015-03-13 Limacorporate Spa Idrogel biocompatibile per uso biomedico o farmaceutico, polimero intermedio per realizzare detto idrogel biocompatibile e relativo metodo di realizzazione
US20150141910A1 (en) * 2013-11-14 2015-05-21 University Medical Pharmaceuticals Corporation Microneedles for therapeutic agent delivery with improved mechanical properties
EP3101064B1 (en) * 2014-01-31 2020-07-15 Seikagaku Corporation Diamine crosslinking agent, acidic polysaccharide crosslinked body, and medical material
US11254792B2 (en) 2015-12-29 2022-02-22 Galderma Holding SA Method for deacetylation of biopolymers
US11337994B2 (en) 2016-09-15 2022-05-24 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
BR112019005391A2 (pt) 2016-09-21 2019-06-04 Nestlé Skin Health Sa métodos para preparar uma composição de hidrogel injetável esterilizada e para tratar cosmeticamente a pele, e, composição de hidrogel injetável esterilizada.
SG10202107829YA (en) 2017-03-22 2021-08-30 Genentech Inc Hydrogel cross-linked hyaluronic acid prodrug compositions and methods
WO2019001784A1 (en) 2017-06-28 2019-01-03 Nestlé Skin Health Sa Hyaluronic acid gel with a divalent cation
CN107469090B (zh) * 2017-08-15 2020-05-12 浙江大学 可共载抗肿瘤药物和核酸药物的纳米载体及抗肿瘤药物纳米制剂
CN111228653A (zh) 2018-11-13 2020-06-05 格莱科米拉治疗公司 用电离辐射加强癌症治疗的方法
EP3659632A1 (en) 2018-11-29 2020-06-03 Nestlé Skin Health SA Post-crosslinking partial degradation of amide crosslinked hydrogels
JP2022529953A (ja) * 2019-04-19 2022-06-27 ジョインセラピュイティクス エッセ．エッレ．エッレ． 官能化ヒアルロン酸の架橋ポリマーと、炎症状態の治療におけるその使用
CN110123741B (zh) * 2019-06-24 2022-02-08 中国医学科学院基础医学研究所 一种铁交联透明质酸纳米凝胶、其制备方法以及用途
CN110684211B (zh) * 2019-10-14 2022-07-12 宁夏妙朗生物科技有限公司 制备抵抗α-葡萄糖苷酶水解的交联右旋糖苷凝胶的方法
AU2020395955A1 (en) 2019-12-02 2022-07-14 Galderma Holding SA High molecular weight esthetic compositions
JP2023551145A (ja) 2020-11-18 2023-12-07 ベクソン バイオメディカル，インク． 医薬化合物の錯化剤塩製剤
WO2022109050A1 (en) * 2020-11-18 2022-05-27 Bexson Biomedical, Inc. Complexing agent salt formulations of pharmaceutical compounds
US12582742B2 (en) 2021-03-11 2026-03-24 Bausch + Lomb Ireland Limited Packaging solutions
WO2023148619A1 (en) 2022-02-01 2023-08-10 Galderma Holding SA Methods of producing crosslinked hyaluronic acid hydrogels
CN114561046B (zh) * 2022-02-28 2023-10-27 江南大学 一种胍基透明质酸型抗菌水凝胶及其制备方法和应用
WO2026022744A1 (en) 2024-07-24 2026-01-29 Galderma Holding SA High-durability glycosaminoglycan gels and methods of making the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716224A (en) * 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
SE8501022L (sv) * 1985-03-01 1986-09-02 Pharmacia Ab Format alster och forfarande for dess framstellning
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
RU2113221C1 (ru) * 1990-05-04 1998-06-20 Ииссум Рисерч Дивелопмент Компани оф дзе Хебрю Юниверсити оф Иеруcалим Фармацевтическая форма для введения лекарственного средства в ободочную кишку, способ введения лекарственного препарата и способ получения матриц для такой формы
RU2017751C1 (ru) * 1991-05-22 1994-08-15 Институт пищевых веществ РАН Способ получения гиалуроновой кислоты
UA35578C2 (uk) * 1991-08-16 2001-04-16 Майлс Е. Гелін Передньокамерний очний імплантат, спосіб його одержання та спосіб лікування короткозорості
IT1254170B (it) * 1991-12-18 1995-09-11 Mini Ricerca Scient Tecnolog Membrane composite per la rigenerazione guidata di tessuti
CA2076732C (en) * 1992-04-17 2006-05-09 Kimberly-Clark Worldwide, Inc. Modified polysaccharides having improved absorbent properties and process for the preparation thereof
JPH06154596A (ja) * 1992-11-18 1994-06-03 Sanyo Chem Ind Ltd 耐塩安定性吸収剤及びその製法
US5616568A (en) * 1993-11-30 1997-04-01 The Research Foundation Of State University Of New York Functionalized derivatives of hyaluronic acid
JPH0959303A (ja) * 1995-08-22 1997-03-04 Shiseido Co Ltd 生体適合性ヒアルロン酸ゲル及びその用途
FR2752843B1 (fr) * 1996-08-30 1998-10-16 Sod Conseils Rech Applic Copolymeres reticules a base de polymeres polycarboxyliques et leur utilisation comme support de composition pharmaceutique
IT1303738B1 (it) * 1998-11-11 2001-02-23 Aquisitio S P A Processo di reticolazione di polisaccaridi carbossilati.

Also Published As

Publication number Publication date
CN1131241C (zh) 2003-12-17
HK1041011B (zh) 2004-10-08
RU2230752C2 (ru) 2004-06-20
IT1303735B1 (it) 2001-02-23
ES2184521T3 (es) 2003-04-01
DE69903351D1 (de) 2002-11-07
EP1144459B2 (en) 2011-02-23
ZA200103799B (en) 2002-08-12
HUP0104296A3 (en) 2003-12-29
CA2350667A1 (en) 2000-05-18
DK1144459T4 (da) 2011-06-06
BR9915235A (pt) 2001-07-24
CN1328573A (zh) 2001-12-26
CZ296842B6 (cs) 2006-06-14
ES2184521T5 (es) 2011-06-13
PT1144459E (pt) 2003-01-31
DE69903351T3 (de) 2012-02-09
KR20010101001A (ko) 2001-11-14
EP1144459A2 (en) 2001-10-17
JP2002529550A (ja) 2002-09-10
CZ20011650A3 (cs) 2001-09-12
WO2000027887A2 (en) 2000-05-18
US6831172B1 (en) 2004-12-14
DE69903351T2 (de) 2003-07-03
NO20012315L (no) 2001-07-06
HUP0104296A2 (hu) 2002-03-28
NZ511306A (en) 2003-05-30
HK1041011A1 (en) 2002-06-28
ITMI982440A1 (it) 2000-05-11
ATE225371T1 (de) 2002-10-15
WO2000027887A3 (en) 2000-11-16
IL143063A0 (en) 2002-04-21
HU229668B1 (en) 2014-04-28
AU2660000A (en) 2000-05-29
EP1144459B1 (en) 2002-10-02
TR200101324T2 (tr) 2001-09-21
KR100674177B1 (ko) 2007-01-24
AU757102B2 (en) 2003-01-30
NO20012315D0 (no) 2001-05-10

Similar Documents

Publication Publication Date Title
DK1144459T3 (da) Tværbundne hyaluronsyrer og medicinske anvendelser deraf
DK1163274T3 (da) Fremgangsmåde til tværbinding af hyaluronsyre til polymerer
DK1312609T3 (da) Boronsyreester- og syreforbindelser, deres syntese og anvendelser
DK1054906T3 (da) Polymerisationsproces med levende karakteristika og polymerer fremstillet derved
CY1106602T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
BR9710994A (pt) Derivados anticonvulsivos úteis no tratamento de obesidade.
ATE263579T1 (de) Abgabe von polyethylene glycol-molekül- konjugaten aus abbaubarem hydrogel
EP0659780A3 (en) Acrylamide polymers and their use.
DE69409176D1 (de) Polymerherstellungsverfahren
BR9814230A (pt) Método de produção de uman-(di-alquil-amino-alquil) (metil) acrilamida ematerial superabsorvente
NO990935D0 (no) Kryssbundne kopolymerer basert pÕ polymerer inneholdende karboksylsyre
DK235687A (da) Tilberedninger til syntese af prostaglandiner og hydroxyfedtsyrer i biologiske systemer og anvendelse deraf
NO20073914L (no) Biologisk aktive peptider
IT1317091B1 (it) Gel di acido ialuronico cross-linked con l-amminoacidi ol-amminoesteri bifunzionali.
DK0994732T3 (da) Absorberende struktur omfattende en stærkt absorberende polymer og en absorberende artikel omfattende den absorberende struktur
IT1308679B1 (it) Monomeri di reticolazione per fotoresist e procedimento per lapreparazione di polimeri fotoresist utilizzanti tali monomeri.
NO995844L (no) Lumino/merkede polymerer for behandling av industrielle systemer
NO964238L (no) Halofantrin-fri-base for behandling av malaria og blandinger
FI944372A7 (fi) Uusi järjestelmä ilman kosteudessa kovettuvien polymeerien verkkoutumisen kiihdyttämiseksi
FI970679A7 (fi) Hydroksialkaanihapoista muodostettujen polymeerien valmistus
ES2127636T3 (es) Procedimiento para la obtencion de polimeros con unidades recurrentes de succinilo.
NL1012219A1 (nl) Werkwijze voor de polymersitie van overzadigde polyalkylpiperidinen.
DE69200786D1 (de) Metallvernetztes Polymergel und dessen Brechen.
IT1307223B1 (it) Catalizzatore per la polimerizzazione di alfa-olefine e procedimentoper la produzione di un polimero alfa-olefinico.
ITTO940892A0 (it) Polimero anionico, ad esempio di tipo superassorbente e relativo procedimento di produzione.